XSPRAY PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.45 SEK | +0.50% |
|
+2.53% | +1.12% |
Chart calendar Xspray Pharma AB
69.AUiLGBARnmR7v4SjDLAHKXnzJJmXANsEXh8X29iQVag.RHjvICd21EkL0en6dsYzTAyYUqHVarZOHWd26YrWIOdoBrNQYnzfLDLzsA~c84c4ed4087951cf6c74b6de0a1a601b
Upcoming events on Xspray Pharma AB
Past events on Xspray Pharma AB
| 2024-03-20 06:10 am | Redeye Theme: Commercialization in Life Science |
| 2024-02-13 | Q4 2023 Earnings Release |
| 2024-01-24 07:19 am | Redeye Theme: Fight Cancer |
| 2023-11-07 | Q3 2023 Earnings Release |
| 2023-08-01 | Q2 2023 Earnings Release |
| 2023-06-01 12:00 am | Redeye Growth Day |
| 2023-05-24 | Extraordinary Shareholders Meeting |
| 2023-05-16 04:00 am | Annual General Meeting |
| 2023-05-03 | Q1 2023 Earnings Release |
| 2023-03-06 | Redeye Commercialization Conference |
| 2023-02-14 | FY 2022 Earnings Release |
| 2023-01-19 12:00 am | Redeye Fight Cancer Seminar |
| 2022-12-12 06:00 pm | American Society of Hematology Meeting |
| 2022-11-26 | Redeye Life Science Day_Interview |
| 2022-11-08 | Q3 2022 Earnings Release |
| 2022-09-06 | Pareto Securities Healthcare Conference |
| 2022-08-05 02:30 am | Interim 2022 Earnings Release |
| 2022-05-19 05:00 am | Annual General Meeting |
| 2022-05-06 02:30 am | Q1 2022 Earnings Release |
| 2022-02-17 | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,42 - | 0,00 0,22 - | 131 |
|
EBITDA Million SEK | Released Forecast Spread | -41,8 -72,0 42% | 0,00 | -89,1 -63,8 -39.57% | -124 -239 48.33% | -173 -153 -12.44% | -278 |
|
EBIT Million SEK | Released Forecast Spread | -46,6 -73,0 36.21% | 0,00 | -98,0 -68,3 -43.36% | -133 -239 44.34% | -182 -159 -13.97% | -293 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -45,8 -73,0 37.3% | 0,00 | -96,7 -75,4 -28.2% | -132 -238 44.64% | -180 -88,9 -102.08% | 754 |
|
Net income Million SEK | Released Forecast Spread | -45,8 -73,0 37.3% | -52,4 | -96,7 -75,4 -28.2% | -132 -238 44.64% | -180 -88,9 -102.06% | 596 |
|
EPS SEK | Released Forecast Spread | -3,01 0,00 - | -3,05 | -5,03 -3,96 -27.05% | -6,25 -8,55 26.88% | -6,76 -3,20 -111.53% | 21,4 |
| Announcement Date | 28/02/20 | 25/02/21 | 18/02/22 | 15/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|---|---|---|
|
EBITDA Million SEK | Released Forecast Spread | -50,0 -31,0 -61.32% | -17,0 -60,0 71.73% | -26,8 -22,0 -21.92% | -26,6 -60,0 55.68% | -53,2 -60,0 11.4% |
|
EBIT Million SEK | Released Forecast Spread | -52,3 -31,0 -68.73% | -19,3 -60,0 67.86% | -29,2 -22,0 -32.77% | -29,0 -60,0 51.68% | -55,6 -60,0 7.36% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -51,9 -30,7 -69.35% | -18,9 -59,0 67.91% | -28,9 -22,0 -31.45% | -28,7 -59,5 51.81% | -55,2 -59,5 7.12% |
|
Net income Million SEK | Released Forecast Spread | -51,9 -30,7 -69.35% | -18,9 -59,0 67.91% | -28,9 -22,0 -31.45% | -28,7 -59,5 51.81% | -55,2 -59,5 7.12% |
|
EPS SEK | Released Forecast Spread | -2,62 -1,48 -76.65% | -0,92 -2,53 63.64% | -1,40 -0,93 -50.06% | -1,39 -2,53 44.97% | -2,48 -2,14 -16.06% |
| Announcement Date | 18/02/22 | 06/05/22 | 05/08/22 | 09/11/22 | 15/02/23 |
More events
Past sector events for Xspray Pharma AB
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- XSPRAY Stock
- Calendar Xspray Pharma AB
